Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Obesity

  Free Subscription


Articles published in Eur J Endocrinol

Retrieve available abstracts of 65 articles:
HTML format



Single Articles


    February 2025
  1. KAHVECI A, Kurt I, Turan S, Guran T, et al
    Real-life experience on efficacy and safety of setmelanotide treatment in prepubertal children.
    Eur J Endocrinol. 2025;192:K15-K18.
    PubMed     Abstract available


  2. BRACHS S, Soll D, Beer F, Huckauf N, et al
    Hormonal regulation of human adipose tissue lipolysis: impact of adipose GIP system in overweight and obesity.
    Eur J Endocrinol. 2025;192:91-99.
    PubMed     Abstract available


    November 2024
  3. MILLER C, Madden-Doyle L, Jayasena C, McIlroy M, et al
    Mechanisms in endocrinology: hypogonadism and metabolic health in men-novel insights into pathophysiology.
    Eur J Endocrinol. 2024;191:R1-R17.
    PubMed     Abstract available


    September 2024
  4. PADILLA C, Stratakis CA, Tatsi C
    The phenotype of the pediatric patient with Cushing syndrome but without obesity.
    Eur J Endocrinol. 2024 Sep 17:lvae114. doi: 10.1093.
    PubMed     Abstract available


    August 2024
  5. LECOQ AL, Schilbach K, Rocher L, Trabado S, et al
    Metabolically healthy obesity in adults with X-linked hypophosphatemia.
    Eur J Endocrinol. 2024;191:156-165.
    PubMed     Abstract available


    July 2024
  6. TRUEBA-TIMMERMANS DJ, Grootjen LN, Kerkhof GF, Rings EHHM, et al
    Thyroid hormone levels in children with Prader-Willi Syndrome: A randomized controlled Growth Hormone (GH)-trial and 10-year GH study.
    Eur J Endocrinol. 2024 Jul 25:lvae088. doi: 10.1093.
    PubMed     Abstract available


  7. WINCKELMANN LA, Gribsholt SB, Bodkergaard K, Rejnmark L, et al
    Risk of fractures following bariatric surgery with Roux-en-Y gastric bypass or sleeve gastrectomy: a Danish population-based cohort study.
    Eur J Endocrinol. 2024;191:1-8.
    PubMed     Abstract available


  8. KWOK TC, Ramage LE, Kelman A, Suchacki KJ, et al
    UCP1 expression in human brown adipose tissue is inversely associated with cardiometabolic risk factors.
    Eur J Endocrinol. 2024;191:106-115.
    PubMed     Abstract available


    March 2024
  9. VAN BEIJSTERVELDT IALP, van Zelst BD, Dorrepaal DJ, van den Berg SAA, et al
    Early life poly- and perfluoroalkyl substances (PFAS) levels and adiposity in the first 2 years of life.
    Eur J Endocrinol. 2024 Mar 30:lvae039. doi: 10.1093.
    PubMed     Abstract available


  10. GATTA-CHERIFI B, Mohammedi K, Cariou T, Poitou C, et al
    Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial.
    Eur J Endocrinol. 2024 Mar 7:lvae024. doi: 10.1093.
    PubMed     Abstract available


    February 2024
  11. FERNANDEZ-GARCIA P, Taxeras SD, Reyes-Farias M, Gonzalez L, et al
    Claudin-1 as a novel target gene induced in obesity and associated to inflammation, fibrosis and cell differentiation.
    Eur J Endocrinol. 2024 Feb 20:lvae018. doi: 10.1093.
    PubMed     Abstract available


    November 2023
  12. LEE J, Jung JH, Kim J, Jeong C, et al
    Associations between body composition and the risk of fracture according to bone mineral density in postmenopausal women: a population-based database cohort study.
    Eur J Endocrinol. 2023;189:527-536.
    PubMed     Abstract available


    October 2023
  13. GATTA-CHERIFI B, Laboye A, Gronnier C, Monsaingeon-Henry M, et al
    A novel pathogenic variant in MRAP2 in an obese patient with successful outcome of bariatric surgery.
    Eur J Endocrinol. 2023;189:K15-K18.
    PubMed     Abstract available


  14. PLUIMAKERS VG, van Atteveld JE, de Winter DTC, Bolier M, et al
    Prevalence, risk factors and optimal way to determine overweight, obesity and morbid obesity, in the first Dutch cohort of 2,338 long-term survivors of childhood cancer: a DCCSS-LATER study.
    Eur J Endocrinol. 2023 Oct 14:lvad139. doi: 10.1093.
    PubMed     Abstract available


    August 2023
  15. JONES TH, Dobs AS, Randeva H, Moore W, et al
    Leflutrozole in Male Obesity-Associated Hypogonadotropic Hypogonadism: Ph 2b Double-Blind Randomised Controlled Trial.
    Eur J Endocrinol. 2023 Aug 14:lvad099. doi: 10.1093.
    PubMed     Abstract available


  16. INDER WJ, Grossmann M
    Obesity and 'functional hypogonadism' - mechanisms and management: Commentary on EJE-22-1110 "Leflutrozole in Male Obesity-Associated Hypogonadotropic Hypogonadism: Ph 2b Double-Blind RCT".
    Eur J Endocrinol. 2023 Aug 7:lvad100. doi: 10.1093.
    PubMed    


    July 2023
  17. TRUEBA-TIMMERMANS DJ, Grootjen LN, Juriaans AF, Mahabier EF, et al
    Cognitive function during 3 years of growth hormone in previously growth hormone-treated young adults with Prader-Willi syndrome.
    Eur J Endocrinol. 2023;189:132-139.
    PubMed     Abstract available


  18. OLLILA MM, Hoek A, Piltonen TT
    The association between polycystic ovary syndrome and early cardiovascular disease morbidity strengthens.
    Eur J Endocrinol. 2023;189:R4-R5.
    PubMed    


  19. SIMCHONI M, Derazne E, Pinhas-Hamiel O, Cukierman-Yaffe T, et al
    Adolescent body mass index and cognitive performance: a nationwide study of 2.48 million Israeli adolescents.
    Eur J Endocrinol. 2023;188:630-640.
    PubMed     Abstract available


    June 2023
  20. EZQUERRO S, Tuero C, Becerril S, Valenti V, et al
    Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated NAFLD.
    Eur J Endocrinol. 2023 Jun 26:lvad071. doi: 10.1093.
    PubMed     Abstract available


  21. DWIVEDI AK, Vishwakarma D, Dubey P, Reddy S, et al
    Association of polycystic ovary syndrome with cardiovascular disease among female hospitalizations in the United States.
    Eur J Endocrinol. 2023;188:555-563.
    PubMed     Abstract available


    April 2023
  22. CANNARELLA R, Caruso M, Condorelli RA, Timpanaro TA, et al
    Testicular volume in 268 children and adolescents followed-up for childhood obesity-a retrospective cross-sectional study.
    Eur J Endocrinol. 2023;188:331-342.
    PubMed     Abstract available


    March 2023
  23. SONNEFELD L, Rohmann N, Geisler C, Laudes M, et al
    Is human obesity an inflammatory disease of the hypothalamus?
    Eur J Endocrinol. 2023 Mar 8:lvad030. doi: 10.1093.
    PubMed     Abstract available


  24. BECKHAUS J, Friedrich C, Boekhoff S, Calaminus G, et al
    Outcome after pediatric craniopharyngioma: the role of age at diagnosis and hypothalamic damage.
    Eur J Endocrinol. 2023;188:lvad027.
    PubMed     Abstract available


    February 2023
  25. GU P, Ding K, Lu L, Zhang Y, et al
    Compromised browning in white adipose tissue of ageing people.
    Eur J Endocrinol. 2023;188:lvad014.
    PubMed     Abstract available


    October 2022
  26. PEKKARINEN L, Kantonen T, Rebelos E, Latva-Rasku A, et al
    Obesity risk is associated with brain glucose uptake and insulin resistance.
    Eur J Endocrinol. 2022 Oct 1. pii: EJE-22-0509. doi: 10.1530/EJE-22-0509.
    PubMed     Abstract available


    September 2022
  27. VILACA T, Evans A, Gossiel F, Paggiosi M, et al
    Fat, adipokines, bone structure and bone regulatory factors associations in obesity.
    Eur J Endocrinol. 2022 Sep 1. pii: EJE-22-0530. doi: 10.1530/EJE-22-0530.
    PubMed     Abstract available


    June 2022
  28. ROSEN CJ
    3E: My Quarter Century Quest to Understand the Paradox of Marrow Adiposity.
    Eur J Endocrinol. 2022 Jun 1. pii: EJE-22-0499. doi: 10.1530/EJE-22-0499.
    PubMed     Abstract available


    May 2022
  29. BLAGOJEVIC C, Heung T, Malecki S, Ying S, et al
    Hypertriglyceridemia in young adults with a 22q11.2 microdeletion.
    Eur J Endocrinol. 2022;187:91-99.
    PubMed     Abstract available


    April 2022
  30. MATHIESEN DS, Lund A, Holst JJ, Knop FK, et al
    THERAPY OF ENDOCRINE DISEASE: Amylin and calcitonin - physiology and pharmacology.
    Eur J Endocrinol. 2022;186:R93-R111.
    PubMed     Abstract available


  31. GOEDEGEBUURE WJ, van der Steen M, Smeets CCJ, Kerkhof GF, et al
    SGA-born adults with postnatal catch-up have a persistently unfavorable metabolic health profile and increased adiposity at age 32 years.
    Eur J Endocrinol. 2022 Apr 1. pii: EJE-21-1130. doi: 10.1530/EJE-21-1130.
    PubMed     Abstract available


    March 2022
  32. HUYNH K, Klose M, Krogsgaard K, Drejer J, et al
    Randomized Controlled Trial of Tesomet for Weight Loss in Hypothalamic Obesity.
    Eur J Endocrinol. 2022 Mar 1. pii: EJE-21-0972. doi: 10.1530/EJE-21-0972.
    PubMed     Abstract available


  33. RUIZ S, Vazquez F, Pellitero S, Puig Domingo M, et al
    Pituitary dysfunction in obesity.
    Eur J Endocrinol. 2022 Mar 1. pii: EJE-21-0899. doi: 10.1530/EJE-21-0899.
    PubMed     Abstract available


  34. DICHTEL LE, Haines MS, Gerweck AV, Bollinger B, et al
    Impact of GH administration on skeletal endpoints in adults with overweight/obesity.
    Eur J Endocrinol. 2022 Mar 1. pii: EJE-21-1061. doi: 10.1530/EJE-21-1061.
    PubMed     Abstract available


    February 2022
  35. KOH HE, van Vliet S, Cao C, Patterson BW, et al
    Effect of obstructive sleep apnea on glucose metabolism.
    Eur J Endocrinol. 2022;186:457-467.
    PubMed     Abstract available


  36. LAUGESEN K, Sorensen HT, Jorgensen JOL, Petersen I, et al
    Prenatal exposure to glucocorticoids and the prevalence of overweight or obesity in childhood.
    Eur J Endocrinol. 2022 Feb 1. pii: EJE-21-0846.R1. doi: 10.1530/EJE-21-0846.
    PubMed     Abstract available


  37. DHINDSA S, Ghanim H, Jenkins T, Inge TH, et al
    High prevalence of subnormal testosterone in obese adolescent males: reversal with bariatric surgery.
    Eur J Endocrinol. 2022;186:319-327.
    PubMed     Abstract available


  38. KUFE C, Micklesfield LK, Masemola M, Chikowore T, et al
    Increased Risk for Type 2 Diabetes in Relation to Adiposity in Middle-Aged Black South African Men compared to Women.
    Eur J Endocrinol. 2022 Feb 1. pii: EJE-21-0527. doi: 10.1530/EJE-21-0527.
    PubMed     Abstract available


    January 2022
  39. LOH NY, Humphreys E, Karpe F, Tomlinson JW, et al
    Sex hormones, adiposity, and metabolic traits in men and women: a Mendelian Randomisation study.
    Eur J Endocrinol. 2022 Jan 1. pii: EJE-21-0703.R2. doi: 10.1530/EJE-21-0703.
    PubMed     Abstract available


    December 2021
  40. SONG Z, Gao M, Lv J, Yu C, et al
    Metabolically healthy obesity, transition to unhealthy phenotypes and type 2 diabetes in 0.5 million Chinese adults: The China Kadoorie Biobank.
    Eur J Endocrinol. 2021 Dec 1. pii: EJE-21-0743.R1. doi: 10.1530/EJE-21-0743.
    PubMed     Abstract available


  41. MAN S, Gao Y, Lv J, Tong M, et al
    Metabolically healthy obesity was significantly associated with increased risk of gallstones.
    Eur J Endocrinol. 2021 Dec 1. pii: EJE-21-0802.R2. doi: 10.1530/EJE-21-0802.
    PubMed     Abstract available


  42. MOHSENI-TAKALLOO S, Beigrezaei S, Yazdanpanah Z, Rajaie SH, et al
    Does exercise beneficially affect sex hormones when added to hypo-caloric diets in adults with overweight or obesity? A systematic review and meta-analysis of controlled clinical trials.
    Eur J Endocrinol. 2021 Dec 1. pii: EJE-21-0675.R1. doi: 10.1530/EJE-21-0675.
    PubMed     Abstract available


    November 2021
  43. DIETZ DE LOOS A, Jiskoot G, Beerthuizen A, Busschbach J, et al
    Metabolic health during a randomized controlled lifestyle intervention in women with PCOS.
    Eur J Endocrinol. 2021;186:53-64.
    PubMed     Abstract available


  44. RUSSELL N, Hoermann R, Cheung AS, Zajac JD, et al
    Effects of estradiol on fat in men undergoing androgen deprivation therapy: a randomized trial.
    Eur J Endocrinol. 2021;186:9-23.
    PubMed     Abstract available


  45. ZHANG J, Chen X, Liu W, Zhang C, et al
    Metabolic surgery improves the unbalanced proportion of peripheral blood myeloid dendritic cells and T lymphocytes in obese patients.
    Eur J Endocrinol. 2021;185:819-829.
    PubMed     Abstract available


  46. MANGOLIM AS, Brito LAR, Nunes-Nogueira VDS
    Effectiveness of testosterone replacement in men with obesity: a systematic review and meta-analysis.
    Eur J Endocrinol. 2021 Nov 1. pii: EJE-21-0473.R1. doi: 10.1530/EJE-21-0473.
    PubMed     Abstract available


  47. YANG R, Hu Y, Lee CH, Liu Y, et al
    PM20D1 Is a Circulating Biomarker Closely Associated with Obesity, Insulin resistance and Metabolic Syndrome.
    Eur J Endocrinol. 2021 Nov 1. pii: EJE-21-0847.R1. doi: 10.1530/EJE-21-0847.
    PubMed     Abstract available


    October 2021
  48. ROMERO-RUIZ A, Pineda B, Ovelleiro D, Perdices-Lopez C, et al
    Molecular diagnosis of polycystic ovary syndrome in obese and non-obese women by targeted plasma miRNA profiling.
    Eur J Endocrinol. 2021;185:637-652.
    PubMed     Abstract available


    September 2021
  49. ANDERSEN MR, Suppli MP, Bagger JI, Christensen MB, et al
    MECHANISMS IN ENDOCRINOLOGY: The physiology of neuronostatin.
    Eur J Endocrinol. 2021;185:R93-R101.
    PubMed     Abstract available


    August 2021
  50. NOGUEIRAS R
    MECHANISMS IN ENDOCRINOLOGY: The gut-brain axis: regulating energy balance independent of food intake.
    Eur J Endocrinol. 2021;185:R75-R91.
    PubMed     Abstract available


    June 2021
  51. LEITER A, Carroll E, De Alwis S, Brooks D, et al
    Metabolic disease and adverse events from immune checkpoint inhibitors.
    Eur J Endocrinol. 2021;184:857-865.
    PubMed     Abstract available


    May 2021
  52. GROOTJEN LN, Rutges JPHJ, Damen L, Donze SH, et al
    Effects of 8 years of growth hormone treatment on scoliosis in children with Prader-Willi syndrome.
    Eur J Endocrinol. 2021;185:47-55.
    PubMed     Abstract available


  53. DAMEN L, Grootjen LN, Donze SH, de Graaff LCG, et al
    Bone mineral density during 3 years of growth hormone in previously GH-treated young adults with PWS.
    Eur J Endocrinol. 2021;184:773-782.
    PubMed     Abstract available


  54. MCNEILL BT, Suchacki KJ, Stimson RH
    MECHANISMS IN ENDOCRINOLOGY: Human brown adipose tissue as a therapeutic target: warming up or cooling down?
    Eur J Endocrinol. 2021;184:R243-R259.
    PubMed     Abstract available


  55. SUBRAMANIAN A, Anand A, Adderley NJ, Okoth K, et al
    Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study.
    Eur J Endocrinol. 2021;184:637-645.
    PubMed     Abstract available


  56. DE ZEGHER F, Ibanez L
    On the rising incidence of early breast development: puberty as an adaptive escape from ectopic adiposity in mismatch girls.
    Eur J Endocrinol. 2021 May 1. pii: EJE-21-0287. doi: 10.1530/EJE-21-0287.
    PubMed     Abstract available


  57. LEGER J, Delcour C, De Roux N, Carel JC, et al
    Response to letter to the editor (from De Zegher and Ibanes) (On the rising incidence of early breast development: puberty as an adaptive escape from ectopic adiposity in mismatch girls).
    Eur J Endocrinol. 2021 May 1. pii: EJE-21-0445. doi: 10.1530/EJE-21-0445.
    PubMed     Abstract available


    April 2021
  58. REYES M, Gonzalez L, Ibeas K, Cereijo R, et al
    White adipose tissue-infiltrated CD11b+ myeloid cells are a source of S100A4, a new potential marker of hepatic damage.
    Eur J Endocrinol. 2021;184:533-541.
    PubMed     Abstract available


  59. JUN JE, Kang M, Jin SM, Kim K, et al
    Additive effect of low skeletal muscle mass and abdominal obesity on coronary artery calcification.
    Eur J Endocrinol. 2021 Apr 1. pii: EJE-20-0885.R1. doi: 10.1530/EJE-20-0885.
    PubMed     Abstract available


  60. STENSEN S, Gasbjerg LS, Krogh LL, Skov-Jeppesen K, et al
    Effects of endogenous GIP in patients with type 2 diabetes.
    Eur J Endocrinol. 2021 Apr 1. pii: EJE-21-0135.R1. doi: 10.1530/EJE-21-0135.
    PubMed     Abstract available


    January 2021
  61. VALDES N, Tirosh A, Keil M, Stratakis CA, et al
    Pediatric Cushing's syndrome: greater risk of being overweight or obese after long-term remission and its predictive factors.
    Eur J Endocrinol. 2021;184:179-187.
    PubMed     Abstract available


    December 2020
  62. LAPAUW B, Kaufman JM
    MANAGEMENT OF ENDOCRINE DISEASE: Rationale and current evidence for testosterone therapy in the management of obesity and its complications.
    Eur J Endocrinol. 2020;183:R167-R183.
    PubMed     Abstract available


    November 2020
  63. BEAVERS KM, Greene KA, Yu EW
    MANAGEMENT OF ENDOCRINE DISEASE: Bone complications of bariatric surgery: updates on sleeve gastrectomy, fractures, and interventions.
    Eur J Endocrinol. 2020;183:R119-R132.
    PubMed     Abstract available


  64. POITOU C, Mosbah H, Clement K
    MECHANISMS IN ENDOCRINOLOGY: Update on treatments for patients with genetic obesity.
    Eur J Endocrinol. 2020;183:R149-R166.
    PubMed     Abstract available


    September 2020
  65. VAN DER VALK ES, van der Voorn B, Iyer AM, van den Berg S, et al
    In adults with obesity, copeptin is linked with BMI but is not associated with long-term exposure to cortisol and cortisone.
    Eur J Endocrinol. 2020 Sep 1. pii: EJE-20-0077.R1. doi: 10.1530/EJE-20-0077.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obesity is free of charge.